Chile's Codelco says it has yet to reach missing workers at El Teniente mine-March 2024-www.financetom.com

Chile's Codelco says it has yet to reach missing workers at El Teniente mine

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Chile's Codelco says it has yet to reach missing workers at El Teniente mine

Aug 1, 2025 6:57 AM

SANTIAGO, Aug 1 (Reuters) - Chilean copper producer

Codelco has still not had contact with five missing workers at

El Teniente's Andesita unit following a seismic incident that

killed one person, El Teniente's general manager Andres Music

said on Friday.

He added that the company expected aftershocks from the

incident to diminish in the next 12 hours, allowing Codelco to

begin rescue efforts.

Previous page： Market Chatter: AT&T, Verizon Network Secured After Chinese-linked Salt Typhoon Cyberattack Next page： IDEAYA Biosciences Enters Into Licensing Agreement With Jiangsu Hengrui for Cancer Drug Candidate SHR-4849

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: AT&T, Verizon Network Secured After Chinese-linked Salt Typhoon Cyberattack

Dec 30, 2024

04:37 AM EST, 12/30/2024 (MT Newswires) -- AT&T ( T ) and Verizon (VZ) confirmed that they were hit with cyber attacks from China-linked Salt Typhoon, but their networks are now secure, Reuters reported Saturday, citing the companies. The investigation found that the Chinese government targeted a few individuals with foreign intelligence interests, Reuters reported, citing an AT&T ( T...

IDEAYA Biosciences Enters Into Licensing Agreement With Jiangsu Hengrui for Cancer Drug Candidate SHR-4849

Dec 30, 2024

04:34 AM EST, 12/30/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Sunday it has entered into an exclusive licensing agreement with Jiangsu Hengrui Pharmaceuticals for its experimental cancer drug, SHR-4849. Under the agreement, the drugmaker will develop and commercialize SHR-4849 outside Greater China. Jiangsu Hengrui will be eligible for up to about $1.05 billion in upfront and milestone...

Boeing Shares Fall Over 4% In Monday Premarket As Airplane Maker Faces Scrutiny After Deadliest 737-800 Crash In South Korea

Dec 30, 2024

Boeing Co ( BA ) saw a 4.53% decline in pre-market trading on Monday, according to Benzinga Pro. The drop follows a tragic aviation accident in South Korea, marking the country’s deadliest air disaster. What Happened: The incident occurred on Sunday when a Boeing 737-800 operated by Jeju Air crash-landed at Muan International Airport. The plane, carrying 175 passengers and six crew members, skidded off the runway,...

Telix Pharmaceuticals Submits BLA in US for TLX250-CDx for Kidney Cancer Imaging

Dec 30, 2024

04:18 AM EST, 12/30/2024 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) said over the weekend it filed a biologics license application with the US Food and Drug Administration for TLX250-CDx for the diagnosis and characterization of clear cell renal cell carcinoma, a form of kidney cancer. The regulator is expected to advise the target action date under the Prescription...